Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA-EDOCH14-R in Poor-prognosis DLBCL
NCT01066429Phase 2Unknown
- Sponsor
- Hospital Universitario Príncipe de Asturias
- Start
- Dec 2009
- Primary completion
- Dec 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dexamethasone in diffuse large B-cell lymphoma (DLBCL), sponsored by Hospital Universitario Príncipe de Asturias. Primary endpoint: Efficacy of the EDOCH14-R scheme. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT01066429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01066429.